In financial year 2023, Gland Pharma Limited's expenditure on research and development was valued at over two billion Indian rupees. This Indian company was acquired by Fosun Pharmaceuticals, a Chinese listed pharmaceutical company in 2016.
R&D expenditure of Gland Pharma Limited from financial year 2019 to 2023 (in million Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Revenue of Alliance Pharma product brands 2022
- Basic Statistic Revenue of Lundbeck top products 2021-2023
- Basic Statistic Top drugs based on projected 2024 global sales
- Basic Statistic Cardinal Health's annual operating earnings 2013-2023
- Premium Statistic Implementation of pharma track & trace in Russia 2019, by stage
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Basic Statistic Market share of generics in European countries 2021
- Premium Statistic Revenue of the OTC pharmaceuticals industry worldwide 2017-2028
About the region
10
- Premium Statistic Leading pharmaceutical and drug companies India 2023, by market capitalization
- Premium Statistic Nestle India's net profit 2014-2022
- Premium Statistic Nestle India's total assets 2018-2022
- Premium Statistic Nestle India's net sales 2014-2022
- Premium Statistic Nestle India's total income from operations 2014-2022
- Premium Statistic Nestle India's employees cost 2014-2022
- Premium Statistic Colgate-Palmolive India manufacturing expenses FY 2014-2023
- Premium Statistic Colgate-Palmolive India EBITDA FY 2014-2023
- Premium Statistic Colgate-Palmolive India EBIT FY 2014-2023
- Premium Statistic Colgate-Palmolive India net sales FY 2014-2023
Selected statistics
1
Other regions
10
- Premium Statistic Leading pharmaceutical preparations manufacturers in Spain in 2021
- Premium Statistic AIS's net profit 2015-2023
- Premium Statistic Associated British Foods group revenue worldwide 2008-2022, by sector
- Basic Statistic Reasons for visiting a community pharmacy in Great Britain 2014
- Basic Statistic PJM Interconnection's operating revenue 2015-2017
- Premium Statistic Genomma Lab: revenue 2013-2021
- Basic Statistic producer price index of chemical and pharmaceutical products in Norway 2008-2022
- Premium Statistic Passenger revenue of Southwest Airlines by segment 2016-2022
- Premium Statistic Pharmaceuticals production value in Colombia 2014-2020
- Premium Statistic Value of monthly imports of medical and pharmaceutical products Australia 2020-2023
Related statistics
10
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Lupin's net sales FY 2015-2022
- Premium Statistic Sun Pharma's profit after tax FY 2014-2023
- Premium Statistic Sun Pharma's income FY 2010-2023
- Premium Statistic Cipla's income from operations FY 2014-2023
- Premium Statistic Cipla's profit FY 2009-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
Further related statistics
10
- Revenue of the Bank of Communications 2022
- Total assets of China Vanke 2022
- Celgene's revenue and net income 2006-2018
- Global net sales of Monster Beverage 2008-2022
- Revenue of AT&T by segment 2017-2023, by quarter
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Danone: recurring operating margin by geographical region, 2016-2022
- Net interest income of Deutsche Bank 2006-2022
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Global revenue share of EssilorLuxottica in 2022, by geographical area
Further Content: You might find this interesting as well
Statistics
- Revenue of the Bank of Communications 2022
- Total assets of China Vanke 2022
- Celgene's revenue and net income 2006-2018
- Global net sales of Monster Beverage 2008-2022
- Revenue of AT&T by segment 2017-2023, by quarter
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Danone: recurring operating margin by geographical region, 2016-2022
- Net interest income of Deutsche Bank 2006-2022
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Global revenue share of EssilorLuxottica in 2022, by geographical area
Gland Pharma. (August 8, 2023). R&D expenditure of Gland Pharma Limited from financial year 2019 to 2023 (in million Indian rupees) [Graph]. In Statista. Retrieved March 29, 2024, from https://www.statista.com/statistics/1187044/india-gland-pharma-s-randd-expenditure/
Gland Pharma. "R&D expenditure of Gland Pharma Limited from financial year 2019 to 2023 (in million Indian rupees)." Chart. August 8, 2023. Statista. Accessed March 29, 2024. https://www.statista.com/statistics/1187044/india-gland-pharma-s-randd-expenditure/
Gland Pharma. (2023). R&D expenditure of Gland Pharma Limited from financial year 2019 to 2023 (in million Indian rupees). Statista. Statista Inc.. Accessed: March 29, 2024. https://www.statista.com/statistics/1187044/india-gland-pharma-s-randd-expenditure/
Gland Pharma. "R&d Expenditure of Gland Pharma Limited from Financial Year 2019 to 2023 (in Million Indian Rupees)." Statista, Statista Inc., 8 Aug 2023, https://www.statista.com/statistics/1187044/india-gland-pharma-s-randd-expenditure/
Gland Pharma, R&D expenditure of Gland Pharma Limited from financial year 2019 to 2023 (in million Indian rupees) Statista, https://www.statista.com/statistics/1187044/india-gland-pharma-s-randd-expenditure/ (last visited March 29, 2024)
R&D expenditure of Gland Pharma Limited from financial year 2019 to 2023 (in million Indian rupees) [Graph], Gland Pharma, August 8, 2023. [Online]. Available: https://www.statista.com/statistics/1187044/india-gland-pharma-s-randd-expenditure/